Pregabalin 75mg capsules - incorrect strength printed in one area of foil blister pack

(Teva UK Limited) 25mg has been incorrectly printed in one position of the affected foil packs however is correct in other positions (EL(15)A/07).

12 August 2015

Class 4 medicines defect information

Caution in use

Pharmacy Level

MDR 75-07/15

Product details

Teva UK Limited

Pregabalin 75mg Capsules

PL 00289/1947

Batch number Expiry date Pack size First distributed
018111 Dec 2017 1 x 56 15 Jul 2015

Alert details

Teva UK Limited has notified us of a printing error on some blisters of Pregabalin 75mg capsules from the above batch. The strength is printed in several positions on the foil lid of the blisters. For affected units, the strength is printed incorrectly, as 25mg instead of 75mg, in one position on the foil. The strength is printed correctly in the remaining positions on the foil. See photograph below. The strength is stated correctly on carton labels and in the patient information leaflet. Approximately 1 in 3 blisters are affected by this issue, hence the majority of cartons from this batch are likely to contain 1 or 2 affected blisters

To ensure continuity of supply, affected stock will not be recalled. No further stock with this error will be released to the market, however.

For general enquiries please contact Teva UK Customer Service Team on 0800 590502.

For medical information enquiries contact Teva UK limited by telephone on 0207 5407117 or by email to

Recipients of this drug alert should bring it to the attention of relevant contacts by copy of this letter. Local area teams are asked to forward this to relevant clinics, general practitioners and community pharmacists.

Pregabalin 75mg capsules blister pack

Download documents

Pregabalin 75mg Capsules - drug alert - incorrect strength printed

Published 12 August 2015